DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Belotecan is an investigational drug.
There have been 7 clinical trials for Belotecan. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2009.
The most common disease conditions in clinical trials are Small Cell Lung Carcinoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are Chong Kun Dang Pharmaceutical, Asan Medical Center, and Chonnam National University Hospital.
Recent Clinical Trials for Belotecan
|A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer||Gachon University Gil Medical Center||Phase 1/Phase 2|
|Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial||Chong Kun Dang Pharmaceutical||Phase 2|
|Study to Assess of Belotecan or Topotecan on Daily Schedule in Relapsed Small Cell Lung Cancer (SCLC) Patients||Chong Kun Dang Pharmaceutical||Phase 2|